Zenni Optical vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

Abridge leads in AI visibility (41 vs 21)
Zenni Optical logo

Zenni Optical

UnknownFashion & Apparel

General

San Francisco pioneer DTC online eyewear at $6.95+ complete glasses with 50M+ pairs sold; privately-held disrupting traditional optical retail competing with Warby Parker and EyeBuyDirect for affordable prescription glasses online.

AI VisibilityBeta
Overall Score
D21
Category Rank
#408 of 1158
AI Consensus
72%
Trend
down
Per Platform
ChatGPT
16
Perplexity
14
Gemini
25

About

Zenni Optical is a San Francisco-based direct-to-consumer online eyewear retailer — privately held, founded in 2003 by Jing Wang and Julia Zhen — pioneering the online prescription glasses market by offering hundreds of frame styles with prescription lens fulfillment starting from as low as $6.95, making vision correction accessible at a fraction of the $200-800+ price of traditional optical retail. Estimated at $400+ million in annual revenue with 50+ million pairs of glasses sold to 50+ million customers in over 50 countries, Zenni's low-cost manufacturing (frames produced at owned factories in China) and direct-to-consumer model (no distributor or retailer markup layers) enable the dramatic price advantage over LensCrafters, Sunglass Hut, and independent opticians that made Zenni one of the first successful DTC disruptors.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

21
Overall Score
41
#408
Category Rank
#777
72
AI Consensus
50
down
Trend
up
16
ChatGPT
35
14
Perplexity
49
25
Gemini
33
15
Claude
51
14
Grok
38

Key Details

Category
General
General
Tier
Unknown
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.